פרופ' מיכאל אדלשטיין
בריאות הציבור, אפידמיולוגיה, מחלות מדבקות, בריאות דיגיטלית
CV
Professor Michael Edelstein is a UK-trained Public Health physician specializing in infectious disease and vaccine epidemiology. He joined the Bar-Ilan University Azrieli Faculty of Medicine, based in Safed, as associate professor, in August 2020. His major research interests focus on the equitable delivery of public health programs, harnessing digital tools (and data in particular) to improve public health, applied principally, but not exclusively, to immunization programs.
Prior to joining Bar-Ilan University, Professor Edelstein was responsible for improving vaccine coverage data and optimizing the quality and use of data to improve the national immunization program across the life-course and to reduce inequalities at PHE, England’s national public health agency. He was also a member of England’s national COVID-19 surveillance team. As an honorary associate professor of Public Health at London School of Hygiene and Tropical Medicine, his research focused on barriers and enablers to reducing health inequalities in vaccine programs. He was the president of the infectious diseases section of the European Public Health Association (EUPHA) between 2018 and 2021.
Professor Edelstein is also deputy editor of the journal Epidemiology and Infection, and a fellow of the UK Faculty of Public Health. He serves on the national immunization advisory committee to the Israeli Ministry of Health, and has served on expert groups for the World Health Organization and the European Centre for Disease Prevention and Control. He has over 65 peer-reviewed publications
He can be followed on Twitter: @epi_michael and is always interested in hearing from students with innovative research ideas!
Courses
Epidemiology
Implementation and evaluation of equitable public health interventions
Publications
Selected recent publications:
1. Elsinga J, Kuodi P, Shibli H, Gorelik Y, Zayyad H, Wertheim O, Abu Jabal K, Dror A, Nazzal S, Glikman D, Edelstein M. Changes in quality of life following SARS-CoV-2 infection among Jewish and Arab populations in Israel: a cross-sectional survey. International Journal of Public health (accepted for publication)
2. Int J Infect Dis. 2023 May 6;134:1-7. doi: 10.1016/j.ijid.2023.05.003. Characterization of post-COVID syndromes by symptom cluster and time period up to 12 months post-infection: A systematic review and meta-analysis. Paul Kuodi , Yanay Gorelik , Blessing Gausi , Tomer Bernstine , Michael Edelstein
3. Vaccine. 2023 Mar 31;41(14):2339-2342. doi: 10.1016/j.vaccine.2023.02.043. Epub 2023 Feb 23. Linked poliovirus incidents in the UK, USA and Israel: Silent transmission or missed warnings of vaccine inequity? Ben Kasstan , Tracey Chantler , Blima Marcus, Sandra Mounier-Jack , Vanessa Saliba , Michael Edelstein
4. Int J Med Inform . 2023 Feb;170:104974. doi: 10.1016/j.ijmedinf.2022.104974. Epub 2022 Dec 23. Monitoring the COVID-19 immunisation programme through a national immunisation Management system - England's experience. Elise Tessier, Michael Edelstein, Camille Tsang, Freja Kirsebom, Charlotte Gower, Colin N J Campbell, Mary Ramsay, Joanne White, Nick Andrews, Jamie Lopez-Bernal, Julia Stowe
5. Epidemiol Infect. 2023 Jan 4;151:e16. doi: 10.1017/S0950268822001996. Associations between reported post-COVID-19 symptoms and subjective well-being, Israel, July 2021 - April 2022. Yanay Gorelik, Amiel Dror, Hiba Zayyad, Ofir Wertheim, Kamal Abu Jabal 1 4, Saleh Nazzal, Paul Otiku, Jelte Elsinga, Daniel Glikman 1 3, Michael Edelstein.
6. Equity of the Meningitis B vaccination programme in England, 2016-2018. Tiley KS, White JM, Andrews N, Tessier E, Edelstein M. Vaccine. 2022 Oct 6;40(42):6125-6132. doi: 10.1016/j.vaccine.2022.09.023. Epub 2022 Sep 16.
7. Reasons underlying the intention to vaccinate children aged 5-11 against COVID-19: A cross-sectional study of parents in Israel, November 2021. Morozov NG, Dror AA, Daoud A, Eisenbach N, Kaykov E, Barhoum M, Sheleg T, Sela E, Edelstein M. Hum Vaccin Immunother. 2022 Nov 30;18(6):2112879. doi: 10.1080/21645515.2022.2112879. Epub 2022 Aug 29.
8. Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020-21, Israel. Kuodi P, Gorelik Y, Zayyad H, Wertheim O, Wiegler KB, Abu Jabal K, Dror AA, Nazzal S, Glikman D, Edelstein M. NPJ Vaccines. 2022 Aug 26;7(1):101. doi: 10.1038/s41541-022-00526-5.
9. Antibody-Mediated Immunogenicity Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Following Priming, Boosting, and Hybrid Immunity: Insights From 11 Months of Follow-up of a Healthcare Worker Cohort in Israel, December 2020-October 2021. Edelstein M, Wiegler Beiruti K, Ben-Amram H, Bar-Zeev N, Sussan C, Asulin H, Strauss D, Bathish Y, Zarka S, Abu Jabal K. Clin Infect Dis. 2022 Aug 24;75(1):e572-e578. doi: 10.1093/cid/ciac212.
10. Inequalities in initiation of COVID19 vaccination by age and population group in Israel- December 2020-July 2021. Gorelik Y, Anis E, Edelstein M. Lancet Reg Health Eur. 2022 Jan;12:100234. doi: 10.1016/j.lanepe.2021.100234. Epub 2021 Oct 30.
11. Migration and outbreaks of vaccine-preventable disease in Europe: a systematic review. Deal A, Halliday R, Crawshaw AF, Hayward SE, Burnard A, Rustage K, Carter J, Mehrotra A, Knights F, Campos-Matos I, Majeed A, Friedland JS, Edelstein M, Mounier-Jack S, Hargreaves S; European Society of Clinical Microbiology and Infectious Diseases Study Group for Infections in Travellers and Migrants (ESGITM). Lancet Infect Dis. 2021 Dec;21(12):e387-e398. doi: 10.1016/S1473-3099(21)00193-6. Epub 2021 Oct 6.
12. Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021. Abu Jabal K, Ben-Amram H, Beiruti K, Batheesh Y, Sussan C, Zarka S, Edelstein M. Euro Surveill. 2021 Feb;26(6):2100096. doi: 10.2807/1560-7917.ES.2021.26.6.2100096.
13. Tracking COVID-19 using online search. Lampos V, Majumder MS, Yom-Tov E, Edelstein M, Moura S, Hamada Y, Rangaka MX, McKendry RA, Cox IJ. NPJ Digit Med. 2021 Feb 8;4(1):17. doi: 10.1038/s41746-021-00384-w.
תאריך עדכון אחרון : 24/09/2024
